Opportunity and Strategy Analysis
This report focuses on identifying opportunities and strategies for investing in the global tumor ablation market within the forecast period. It provides a complete analysis of the global market both quantitatively and qualitatively. The quantitative analysis includes market size and revenue data of the total demand, sub-markets, and regional/national levels throughout 2023-2033. Qualitative analysis depicts a full picture of market dynamics and trends including drivers, restraints and challenges, emerging products/market trends, and Porter’s Fiver Forces analysis.
Based on the market data and analysis, the report highlights Increasingly Attractive Segments (IAS) and business opportunities in each segmentation. Moreover, a systematic evaluation of Internal Risks (factors arising within the industry development) and External Risks (factors arising from the surrounding environments) is provided for the tumor ablation industry and market. All the identified risk factors are measured quantitatively according to GMD’s novel numeric system, i.e. each risk is evaluated with GMD Risk Index Number (GMD RIN) and GMD Risk Intensity Level (GMD RIL). This in-depth risk assessment offers a comprehensive understanding of the current risk factors and their developing trends. Furthermore, this report concludes risk management strategies and Critical Success Factors (CSFs) to help companies make intelligence-based business decisions in the global tumor ablation industry.
Market Coverage & Overview
The report is based on studies for 2021-2023 and provides a forecast from 2024 till 2033 with 2023 as the base year. Considering impact of COVID-19 and regional conflicts such as Russia-Ukraine war, the trend and outlook of global market is forecast in optimistic, balanced, and conservative scenarios. In the balanced view, the global tumor ablation market is expected to reach $4.79 billion by 2033, growing by 12.4% annually over the coming years.
Segmentation Analysis
Highlighted with 88 tables and 98 figures, this 187-page report represents a 360-degree view on the global market with extensively detailed segmentations Technology, Component, Treatment, Application, End User, and Region/Country as shown below. Annual revenue 2023-2033 for each segment is included in the report.
By Technology
• Radiofrequency Ablation
• Microwave Ablation
• Irreversible Electroporation Ablation
• Cryoablation
• High-Intensity Focused Ultrasound
• Other Technologies
By Component
• Generators
• Probes/Electrodes
By Treatment
• Surgical Ablation
• Percutaneous Ablation
• Laparoscopic Ablation
By Application
• Lung Cancer
• Kidney Cancer
• Liver Cancer
• Breast Cancer
• Bone Cancer
• Prostate Cancer
• Other Applications
By End User
• Hospital and Clinics
• Specialty Centers
• Other End Users
By Region
• North America (U.S., Canada, and Mexico)
• Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Netherlands, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
• APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
• South America (Brazil, Colombia, Argentina, Rest of South America)
• MEA (UAE, Saudi Arabia, South Africa, and Rest of MEA)
The breakdown of all regional markets by country and the breakdown of each national market by Technology, Treatment, and Application over the forecast years are also included.
Key Companies
The report also covers the current competitive scenario and profiles key vendors including market leaders and important emerging players. A selection of companies profiled in this report includes:
• AngioDynamics Inc.
• Biotronik
• Bioventus Inc. (Misonix Inc.)
• Boston Scientific Corporation
• Chongqing Haifu Medical Technology Co., Ltd.
• CONMED Corporation
• EDAP TMS
• Ethicon, Inc. (Johnson & Johnson)
• HealthTronics, Inc.
• HistoSonics, Inc.
• IceCure Medical Ltd.
• Integra Life Science Holding Corporation
• Medtronic plc
• Mermaid Medical Group
• Olympus Corporation
• Smith & Nephew PLC
• Sonacare Medical
1 Introduction 10
1.1 Industry Definition and Research Scope 10
1.1.1 Industry Definition 10
1.1.2 Research Scope 11
1.2 Research Methodology 14
1.2.1 Overview of Market Research Methodology 14
1.2.2 Market Assumption 15
1.2.3 Secondary Data 15
1.2.4 Primary Data 15
1.2.5 Data Filtration and Model Design 16
1.2.6 Market Size/Share Estimation 17
1.2.7 Research Limitations 18
1.3 Executive Summary 19
2 Market Overview and Dynamics 22
2.1 Market Size and Forecast 22
2.1.1 Impact of COVID-19 on World Economy 23
2.1.2 Impact of COVID-19 on the Market 27
2.1.3 Impact of Russia-Ukraine Conflict 29
2.1.4 Impact of Israel-Palestine War 31
2.2 Major Growth Drivers 32
2.3 Market Restraints and Challenges 37
2.4 Emerging Opportunities and Market Trends 40
2.5 Porter’s Fiver Forces Analysis 43
3 Segmentation of Global Market by Technology 47
3.1 Market Overview by Technology 47
3.2 Radiofrequency Ablation 50
3.3 Microwave Ablation 51
3.4 Irreversible Electroporation Ablation 52
3.5 Cryoablation 53
3.6 High-Intensity Focused Ultrasound 54
3.7 Other Technologies 55
4 Segmentation of Global Market by Component 56
4.1 Market Overview by Component 56
4.2 Generators 59
4.3 Probes/Electrodes 60
5 Segmentation of Global Market by Treatment 61
5.1 Market Overview by Treatment 61
5.2 Surgical Ablation 64
5.3 Percutaneous Ablation 65
5.4 Laparoscopic Ablation 66
6 Segmentation of Global Market by Application 67
6.1 Market Overview by Application 67
6.2 Lung Cancer 70
6.3 Kidney Cancer 71
6.4 Liver Cancer 72
6.5 Breast Cancer 73
6.6 Bone Cancer 74
6.7 Prostate Cancer 75
6.8 Other Applications 76
7 Segmentation of Global Market by End User 77
7.1 Market Overview by End User 77
7.2 Hospital and Clinics 80
7.3 Specialty Centers 81
7.4 Other End Users 82
8 Segmentation of Global Market by Region 83
8.1 Geographic Market Overview 2023-2033 83
8.2 North America Market 2023-2033 by Country 88
8.2.1 Overview of North America Market 88
8.2.2 U.S. 92
8.2.3 Canada 95
8.2.4 Mexico 97
8.3 European Market 2023-2033 by Country 99
8.3.1 Overview of European Market 99
8.3.2 Germany 103
8.3.3 U.K. 105
8.3.4 France 107
8.3.5 Spain 109
8.3.6 Italy 111
8.3.7 Russia 113
8.3.8 Rest of European Market 115
8.4 Asia-Pacific Market 2023-2033 by Country 117
8.4.1 Overview of Asia-Pacific Market 117
8.4.2 Japan 121
8.4.3 China 124
8.4.4 Australia 126
8.4.5 India 128
8.4.6 South Korea 130
8.4.7 Rest of APAC Region 132
8.5 South America Market 2023-2033 by Country 134
8.5.1 Argentina 138
8.5.2 Brazil 140
8.5.3 Colombia 142
8.5.4 Rest of South America Market 144
8.6 MEA Market 2023-2033 by Country 145
8.6.1 UAE 149
8.6.2 Saudi Arabia 151
8.6.3 South Africa 153
8.6.4 Other National Markets 155
9 Competitive Landscape 156
9.1 Overview of Key Vendors 156
9.2 New Product Launch, Partnership, Investment, and M&A 159
9.3 Company Profiles 160
AngioDynamics Inc. 160
Biotronik 162
Bioventus Inc. (Misonix Inc.) 163
Boston Scientific Corporation 164
Chongqing Haifu Medical Technology Co., Ltd. 165
CONMED Corporation 166
EDAP TMS 167
Ethicon, Inc. (Johnson & Johnson) 168
HealthTronics, Inc. 169
HistoSonics, Inc. 170
IceCure Medical Ltd. 171
Integra Life Science Holding Corporation 172
Medtronic plc 173
Mermaid Medical Group 174
Olympus Corporation 175
Smith & Nephew PLC 176
Sonacare Medical 177
10 Investing in Tumor Ablation Industry: Risk Assessment and Management 178
10.1 Risk Evaluation of Global Market 178
10.2 Critical Success Factors (CSFs) 184
RELATED REPORTS 187
List of Tables:
Table 1. Snapshot of Global Tumor Ablation Market in Balanced Perspective, 2023-2033 20
Table 2. World Economic Outlook, 2024-2036 24
Table 3. World Economic Outlook, 2022-2024 26
Table 4. Scenarios for Economic Impact of Ukraine Crisis 30
Table 5. Scenarios for Economic Impact of Israel-Palestine War 31
Table 6. World Health Spending by Region, $ bn, 2013-2020 36
Table 7. Main Product Trends and Market Opportunities in Global Tumor Ablation Market 40
Table 8. Global Tumor Ablation Market by Technology, 2023-2033, $ mn 48
Table 9. Global Tumor Ablation Market by Component, 2023-2033, $ mn 57
Table 10. Global Tumor Ablation Market by Treatment, 2023-2033, $ mn 62
Table 11. Global Tumor Ablation Market by Application, 2023-2033, $ mn 68
Table 12. Global Tumor Ablation Market by End User, 2023-2033, $ mn 78
Table 13. Global Tumor Ablation Market by Region, 2023-2033, $ mn 85
Table 14. Leading National Tumor Ablation Market, 2023 and 2033, $ mn 87
Table 15. North America Tumor Ablation Market by Country, 2023-2033, $ mn 90
Table 16. U.S. Tumor Ablation Market by Technology, 2023-2033, $ mn 94
Table 17. U.S. Tumor Ablation Market by Treatment, 2023-2033, $ mn 94
Table 18. U.S. Tumor Ablation Market by Application, 2023-2033, $ mn 94
Table 19. Canada Tumor Ablation Market by Technology, 2023-2033, $ mn 96
Table 20. Canada Tumor Ablation Market by Treatment, 2023-2033, $ mn 96
Table 21. Canada Tumor Ablation Market by Application, 2023-2033, $ mn 96
Table 22. Mexico Tumor Ablation Market by Technology, 2023-2033, $ mn 98
Table 23. Mexico Tumor Ablation Market by Treatment, 2023-2033, $ mn 98
Table 24. Mexico Tumor Ablation Market by Application, 2023-2033, $ mn 98
Table 25. Europe Tumor Ablation Market by Country, 2023-2033, $ mn 101
Table 26. Germany Tumor Ablation Market by Technology, 2023-2033, $ mn 104
Table 27. Germany Tumor Ablation Market by Treatment, 2023-2033, $ mn 104
Table 28. Germany Tumor Ablation Market by Application, 2023-2033, $ mn 104
Table 29. U.K. Tumor Ablation Market by Technology, 2023-2033, $ mn 106
Table 30. U.K. Tumor Ablation Market by Treatment, 2023-2033, $ mn 106
Table 31. U.K. Tumor Ablation Market by Application, 2023-2033, $ mn 106
Table 32. France Tumor Ablation Market by Technology, 2023-2033, $ mn 108
Table 33. France Tumor Ablation Market by Treatment, 2023-2033, $ mn 108
Table 34. France Tumor Ablation Market by Application, 2023-2033, $ mn 108
Table 35. Spain Tumor Ablation Market by Technology, 2023-2033, $ mn 110
Table 36. Spain Tumor Ablation Market by Treatment, 2023-2033, $ mn 110
Table 37. Spain Tumor Ablation Market by Application, 2023-2033, $ mn 110
Table 38. Italy Tumor Ablation Market by Technology, 2023-2033, $ mn 112
Table 39. Italy Tumor Ablation Market by Treatment, 2023-2033, $ mn 112
Table 40. Italy Tumor Ablation Market by Application, 2023-2033, $ mn 112
Table 41. Russia Tumor Ablation Market by Technology, 2023-2033, $ mn 114
Table 42. Russia Tumor Ablation Market by Treatment, 2023-2033, $ mn 114
Table 43. Russia Tumor Ablation Market by Application, 2023-2033, $ mn 114
Table 44. Tumor Ablation Market in Rest of Europe by Country, 2023-2033, $ mn 116
Table 45. APAC Tumor Ablation Market by Country, 2023-2033, $ mn 119
Table 46. Japan Tumor Ablation Market by Technology, 2023-2033, $ mn 123
Table 47. Japan Tumor Ablation Market by Treatment, 2023-2033, $ mn 123
Table 48. Japan Tumor Ablation Market by Application, 2023-2033, $ mn 123
Table 49. China Tumor Ablation Market by Technology, 2023-2033, $ mn 125
Table 50. China Tumor Ablation Market by Treatment, 2023-2033, $ mn 125
Table 51. China Tumor Ablation Market by Application, 2023-2033, $ mn 125
Table 52. Australia Tumor Ablation Market by Technology, 2023-2033, $ mn 127
Table 53. Australia Tumor Ablation Market by Treatment, 2023-2033, $ mn 127
Table 54. Australia Tumor Ablation Market by Application, 2023-2033, $ mn 127
Table 55. India Tumor Ablation Market by Technology, 2023-2033, $ mn 129
Table 56. India Tumor Ablation Market by Treatment, 2023-2033, $ mn 129
Table 57. India Tumor Ablation Market by Application, 2023-2033, $ mn 129
Table 58. South Korea Tumor Ablation Market by Technology, 2023-2033, $ mn 131
Table 59. South Korea Tumor Ablation Market by Treatment, 2023-2033, $ mn 131
Table 60. South Korea Tumor Ablation Market by Application, 2023-2033, $ mn 131
Table 61. Tumor Ablation Market in Rest of APAC by Country/Region, 2023-2033, $ mn 133
Table 62. South America Tumor Ablation Market by Country, 2023-2033, $ mn 136
Table 63. Argentina Tumor Ablation Market by Technology, 2023-2033, $ mn 139
Table 64. Argentina Tumor Ablation Market by Treatment, 2023-2033, $ mn 139
Table 65. Argentina Tumor Ablation Market by Application, 2023-2033, $ mn 139
Table 66. Brazil Tumor Ablation Market by Technology, 2023-2033, $ mn 141
Table 67. Brazil Tumor Ablation Market by Treatment, 2023-2033, $ mn 141
Table 68. Brazil Tumor Ablation Market by Application, 2023-2033, $ mn 141
Table 69. Colombia Tumor Ablation Market by Technology, 2023-2033, $ mn 143
Table 70. Colombia Tumor Ablation Market by Treatment, 2023-2033, $ mn 143
Table 71. Colombia Tumor Ablation Market by Application, 2023-2033, $ mn 143
Table 72. MEA Tumor Ablation Market by Country, 2023-2033, $ mn 147
Table 73. UAE Tumor Ablation Market by Technology, 2023-2033, $ mn 150
Table 74. UAE Tumor Ablation Market by Treatment, 2023-2033, $ mn 150
Table 75. UAE Tumor Ablation Market by Application, 2023-2033, $ mn 150
Table 76. Saudi Arabia Tumor Ablation Market by Technology, 2023-2033, $ mn 152
Table 77. Saudi Arabia Tumor Ablation Market by Treatment, 2023-2033, $ mn 152
Table 78. Saudi Arabia Tumor Ablation Market by Application, 2023-2033, $ mn 152
Table 79. South Africa Tumor Ablation Market by Technology, 2023-2033, $ mn 154
Table 80. South Africa Tumor Ablation Market by Treatment, 2023-2033, $ mn 154
Table 81. South Africa Tumor Ablation Market by Application, 2023-2033, $ mn 154
Table 82. AngioDynamics Inc.: Company Snapshot 160
Table 83. AngioDynamics Inc.: Business Segmentation 161
Table 84. AngioDynamics Inc.: Product Portfolio 161
Table 85. List of Risk Factors and Weight Percentages/Theoretical Maximum 179
Table 86. Definition of GMD Relative Risk Index Number (Relative RIN) and GMD Risk Intensity Level (RIL) 180
Table 87. Risk Evaluation for Investing in Global Market, 2023-2033 181
Table 88. Critical Success Factors and Key Takeaways 185
